Lexicon Pharmaceuticals | LXRX - Stock





Stock Veränderung Datum
Abbott USD 6.99B 501M 2026-03
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Illumina USD 611M 47M 2026-03
Insmed USD 132.07M 11.1M 2025-12
J&J USD 14.58B 392M 2026-03
Lexicon Pharmaceuticals USD 168K 33K 2025-06
MacroGenics USD 7.91M 840K 2025-12
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Novartis USD 6.29B 17M 2026-03
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12